INSIGHTS ON DRUG DEVELOPMENT
-
Design Scalable Downstream Processes With Practical Strategies
Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.
-
Benchmarking Filtration Performance Of TFF Cassettes
Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.
-
Advancing The Human Liver-Chip Toward FDA Qualification
Explore how human-relevant liver models can improve DILI risk assessment and support stronger development decisions while advancing toward regulatory qualification and scaling into automated studies.
-
From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined
Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.
-
DEORA® : Filling The Gap For Multi-Use, Fixed-Dose Injection Solutions7/1/2026
High biologic demand requires delivery systems that balance simplicity with sustainability. Multi-use, fixed-dose platforms reduce waste, streamline workflows, and secure resilient supply chains.
-
Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success2/26/2025
By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.
-
Take Action On PFAS To Protect Your Critical Processes9/18/2025
PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.
-
Automating High-Throughput Screens Using Patient-Derived Organoids3/17/2025
Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.
-
Using AI-Analysis And High-Content Screening To Improve Data Capturing4/4/2025
Discover an advanced 3D imaging for drug discovery that features high-throughput, high-quality images, modular hardware, and intuitive software for precise, rapid analysis.
DRUG DEVELOPMENT SOLUTIONS
-
Enabling you to design vaccines without reliance on animal sources with our fermentation-produced squalene.
-
CDMOs, CMOs, and those working on pilot to scale-up operations can benefit from this single-use solution for chromatographic purification that offers easy integration and versatility in scale.
-
Natoli’s line of affordable tablet presses is designed, engineered, and manufactured in the U.S.A. and built on our decades of experience in the tableting industry. We know our customers want presses that efficiently meet their R&D and/or production needs.
With Natoli you have a choice in your tablet press: R&D or production, single-station or rotary, fully automated or manual. Whatever your need, Natoli’s best-in-class tablet presses can help you optimize tablet quality while saving time and reducing costs.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
We deliver custom assay development, screening, potency, and selectivity testing services for the pharmaceutical, biopharmaceutical, and agrochemical industries.